- Search results for 1418205-77-2
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "1418205-77-2"!
Close filters
Filter by:
No results were found for the filter!
NEW
Item number: BPS-84255-1
Bimekizumab, also known as CDP4940, is a humanized recombinant monoclonal antibody that can selectively neutralize IL-17A and IL-17F. can be used for research on rheumatoid arthritis and psoriasis. Bimekizumab was been investigated for the treatment of plaque psoriasis, psoriatic arthritis, ankylosing spondylitis...
| Keywords: | IL17A, Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8 |
| Application: | ELISA, FC, FA |
| Host: | Human |
| CAS | 1418205-77-2 |
From 1,175.00€
*
Item number: TGM-T76798-10mg
Description: Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody), a humanized monoclonal antibody, selectively neutralizes IL-17A and IL-17F, which promote osteogenic differentiation in human periosteum-derived cells (hPDC), and consequently inhibits inflammation-driven osteogenic differentiation [1].
| Application: | Targets interleukin 17A (IL17A, CTLA8) |
| CAS | 1418205-77-2 |
From 352.00€
*
